← Eichor
Condition: Arrhythmogenic Cardiomyopathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Arrhythmogenic Cardiomyopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Application of T1 Mapping in Real-World
Phase N/A · 1 location(s) · Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07354646Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated A
Phase 1 · 7 location(s) · Tenaya Therapeutics · NCT06228924Mayo AVC Registry and Biobank
Phase N/A · 2 location(s) · Mayo Clinic · NCT03049254Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
Phase N/A · 1 location(s) · University of Edinburgh · NCT06409585Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arr
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06591260Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic an
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT04521790A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM
Phase N/A · 6 location(s) · Lexeo Therapeutics · NCT06976606Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
Phase 2 · 5 location(s) · Centro Cardiologico Monzino · NCT06922994Tissue and Metabolic Characterization of Arrhythmogenic Cardiomyopathies by Hybrid PET-MRI Imaging, Impact of the Observ
Phase N/A · 5 location(s) · Nantes University Hospital · NCT05450783GEAM Study Aims At Assessing the Role of Genetic Testing in Patients with Arrhythmic Myocarditis.
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06889662Local Inflammation in Arrhythmogenic Right Ventricular Cardiomyopathy
NA · 1 location(s) · University Hospital, Toulouse · NCT05209776Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9)
Phase N/A · 21 location(s) · Tenaya Therapeutics · NCT06311708Clinical Cohort Study - TRUST
Phase N/A · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT05521451Arrhythmogenic Activity During Exercise in ARVC Patients
NA · 1 location(s) · Swiss Federal Institute of Technology · NCT06040242Characterization of Patients With Cardiomyopathy to Identify Critical Patients Candidates for Cardiac Transplantation
Phase N/A · 3 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06813443FAPI PET/CT Imaging in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (FAPI-ARVC))
NA · 1 location(s) · Istanbul University - Cerrahpasa · NCT07563660Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · 13 location(s) · Hospices Civils de Lyon · NCT03593317Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients wit
Phase N/A · 1 location(s) · Scientific Institute San Raffaele · NCT06607471Pediatric Cardiomyopathy Mutation Analysis
Phase N/A · 1 location(s) · Indiana University · NCT02432092Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
Phase 2 · 17 location(s) · Hamilton Health Sciences Corporation · NCT06174220China Structural Ventricular Arrhythmias Registry
Phase N/A · 1 location(s) · China National Center for Cardiovascular Diseases · NCT03821051Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
Phase N/A · 1 location(s) · First Affiliated Hospital Xi'an Jiaotong University · NCT06352307Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate
NA · 1 location(s) · University Hospital Bispebjerg and Frederiksberg · NCT06405750DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studie
Phase N/A · 1 location(s) · University Hospital Heidelberg · NCT04265040Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy
Phase N/A · 4 location(s) · Centro Medico Teknon · NCT06730464Cardiovascular Multimodality Imaging Study
Phase N/A · 1 location(s) · Montefiore Medical Center · NCT06610019National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Un
Phase N/A · 27 location(s) · Hospital do Coracao · NCT06546137Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
Phase N/A · 1 location(s) · St. George's Hospital, London · NCT04257994PKP2-ACM Natural History Study
Phase N/A · 3 location(s) · Rocket Pharmaceuticals Inc. · NCT06644742A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-A
Phase 1 · 3 location(s) · Rocket Pharmaceuticals Inc. · NCT05885412
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.